Jill M. Quigley, Chief Operating Officer at Passage BIO, Inc. (PASG), sold 16,298 shares at $30.10 ($491K) on 2021-01-14, disclosed to the SEC on 2021-01-15.
Scheduled sale ($491k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TERN | SELL | 2024-09-11 | $172K | — | Filing → |
| TERN | SELL | 2024-08-05 | $180K | — | Filing → |
| TERN | SELL | 2024-07-17 | $148K | — | Filing → |